Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03044535 · ClinicalTrials.gov registry record
Mechanical Support Measures of Adjustment and QOL
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 895
- Enrollment target
NCT03044535: Completed study, sponsored by Northwestern University.
NCT03044535 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 895 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03044535 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 895 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a measurement system to assess adjustment to mechanical circulatory support (MCS) (also referred to as a ventricular assist device \[VAD\]) and health-related quality of life (HRQOL) in patients with advanced heart failure who receive a VAD. This investigators refer to this measurement system as Mechanical Circulatory Support: Adjustment and Quality of Life (MCS A-QOL).
Primary Outcome
Psychometric measurement methods will be used to create new "item banks" (sets of items that comprise carefully calibrated questions which define and quantify a common theme) and short forms from our existing MCS A-QOL item pools (library of relevant items). Psychometric properties (e.g., reliability, validity, etc) of these new measures and existing instruments, some of them modified, will be evaluated, in order to provide evidence of their clinical utility for measuring adjustment to MCS and H
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 895 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2020-02-28 |
What the finished NCT03044535 record still lists
NCT03044535 is an observational study that tracks outcomes without assigning an intervention. The registered 895 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03044535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03044535 about?
NCT03044535 is a clinical study titled "Mechanical Support Measures of Adjustment and QOL". The purpose of this study is to develop a measurement system to assess adjustment to mechanical circulatory support (MCS) (also referred to as a ventricular assist device \[VAD\]) and health-related quality of life (HRQOL) in patients with advanced heart failure who receive a VAD. This investigators...
What is the current status of trial NCT03044535?
This trial is currently completed. The enrollment target is 895 participants. The study started on 2016-10-26. Estimated completion is 2020-02-28.
Who is sponsoring clinical trial NCT03044535?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI